_id
69171be43c536f8df2316651
Ticker
TBIO
Name
Telesis Bio Inc.
Exchange
PINK
Address
10431 Wateridge Circle, San Diego, CA, United States, 92121-2993
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://telesisbio.com
Description
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. It has license agreement with Regeneron Pharmaceuticals, Inc. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Last Close
0.05
Volume
-
Current Price
0.051
Change
-78.68852459016394
Last Updated
2026-01-07T12:51:14.919Z
Image
data:image/webp;base64,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
Ipo Date
2021-06-18T00:00:00.000Z
Market Cap
37292
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
4
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-09-30
Revenue
1566000
Cost Of Revenue
557000
Gross Profit
1009000
Operating Expenses
6486000
Operating Income
-5477000
Interest Expense
219000
Pretax Income
-6181000
Net Income
-6642000
Eps
-3.7469050800970067
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
1000
EBITDA
-4677000
Operating Margin
-349.74457215836526
Total Other Income Expense Net
-704000
Cash
3720000
Short Term Investments
794000
Receivables
1262000
Inventories
1099000
Total Current Assets
8120000
Property Plant Equipment
11991000
Total Assets
24737000
Payables
1493000
Short Term Debt
4410000
Long Term Debt
-
Total Liabilities
20863000
Equity
3874000
Bs_currency_symbol
-
Depreciation
791000
Change In Working Capital
-1118000
Cash From Operations
-6959000
Capital Expenditures
55000
Cash From Investing
4446000
Cash From Financing
-168000
Net Change In Cash
-2677000
Cf_currency_symbol
-
PE
-
PB
0.02333655472379969
ROE
-171.45069695405266
ROA
-26.85046691191333
FCF
-7014000
Fcf Percent
-4.478927203065134
Piotroski FScore
0
Health Score
15
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2024-09-30
Quarters > 0 > income Statement > revenue
1566000
Quarters > 0 > income Statement > cost Of Revenue
557000
Quarters > 0 > income Statement > gross Profit
1009000
Quarters > 0 > income Statement > operating Expenses
6486000
Quarters > 0 > income Statement > operating Income
-5477000
Quarters > 0 > income Statement > interest Expense
219000
Quarters > 0 > income Statement > pretax Income
-6181000
Quarters > 0 > income Statement > net Income
-6642000
Quarters > 0 > income Statement > eps
-3.7469050800970067
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1772663
Quarters > 0 > income Statement > income Tax Expense
1000
Quarters > 0 > income Statement > EBITDA
-4677000
Quarters > 0 > income Statement > operating Margin
-349.74457215836526
Quarters > 0 > income Statement > total Other Income Expense Net
-704000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3720000
Quarters > 0 > balance Sheet > short Term Investments
794000
Quarters > 0 > balance Sheet > receivables
1262000
Quarters > 0 > balance Sheet > inventories
1099000
Quarters > 0 > balance Sheet > total Current Assets
8120000
Quarters > 0 > balance Sheet > property Plant Equipment
11991000
Quarters > 0 > balance Sheet > total Assets
24737000
Quarters > 0 > balance Sheet > payables
1493000
Quarters > 0 > balance Sheet > short Term Debt
4410000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
20863000
Quarters > 0 > balance Sheet > equity
3874000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-6642000
Quarters > 0 > cash Flow > depreciation
791000
Quarters > 0 > cash Flow > change In Working Capital
-1118000
Quarters > 0 > cash Flow > cash From Operations
-6959000
Quarters > 0 > cash Flow > capital Expenditures
55000
Quarters > 0 > cash Flow > cash From Investing
4446000
Quarters > 0 > cash Flow > cash From Financing
-168000
Quarters > 0 > cash Flow > net Change In Cash
-2677000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-3.7469050800970067
Quarters > 0 > ratios > PB
0.02333655472379969
Quarters > 0 > ratios > ROE
-171.45069695405266
Quarters > 0 > ratios > ROA
-26.85046691191333
Quarters > 0 > ratios > FCF
-7014000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-4.478927203065134
Quarters > 0 > health Score
15
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
1550000
Quarters > 1 > income Statement > cost Of Revenue
2349000
Quarters > 1 > income Statement > gross Profit
-799000
Quarters > 1 > income Statement > operating Expenses
10692000
Quarters > 1 > income Statement > operating Income
-10474000
Quarters > 1 > income Statement > interest Expense
214000
Quarters > 1 > income Statement > pretax Income
-11560000
Quarters > 1 > income Statement > net Income
-12585000
Quarters > 1 > income Statement > eps
-7.2736835413042344
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1730210
Quarters > 1 > income Statement > income Tax Expense
1000
Quarters > 1 > income Statement > EBITDA
-10544000
Quarters > 1 > income Statement > operating Margin
-675.741935483871
Quarters > 1 > income Statement > total Other Income Expense Net
-1086000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6397000
Quarters > 1 > balance Sheet > short Term Investments
3817000
Quarters > 1 > balance Sheet > receivables
1334000
Quarters > 1 > balance Sheet > inventories
1357000
Quarters > 1 > balance Sheet > total Current Assets
15156000
Quarters > 1 > balance Sheet > property Plant Equipment
30983000
Quarters > 1 > balance Sheet > total Assets
52727000
Quarters > 1 > balance Sheet > payables
1536000
Quarters > 1 > balance Sheet > short Term Debt
3588000
Quarters > 1 > balance Sheet > long Term Debt
5278000
Quarters > 1 > balance Sheet > total Liabilities
42781000
Quarters > 1 > balance Sheet > equity
9946000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-12585000
Quarters > 1 > cash Flow > depreciation
806000
Quarters > 1 > cash Flow > change In Working Capital
2213000
Quarters > 1 > cash Flow > cash From Operations
-5346000
Quarters > 1 > cash Flow > capital Expenditures
81000
Quarters > 1 > cash Flow > cash From Investing
1127000
Quarters > 1 > cash Flow > cash From Financing
-7000
Quarters > 1 > cash Flow > net Change In Cash
-4226000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-7.2736835413042344
Quarters > 1 > ratios > PB
0.00887197969032777
Quarters > 1 > ratios > ROE
-126.53327971043635
Quarters > 1 > ratios > ROA
-23.86822690462192
Quarters > 1 > ratios > FCF
-5427000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.5012903225806453
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
3440000
Quarters > 2 > income Statement > cost Of Revenue
3169000
Quarters > 2 > income Statement > gross Profit
271000
Quarters > 2 > income Statement > operating Expenses
8792000
Quarters > 2 > income Statement > operating Income
-8521000
Quarters > 2 > income Statement > interest Expense
217000
Quarters > 2 > income Statement > pretax Income
-8635000
Quarters > 2 > income Statement > net Income
-8637000
Quarters > 2 > income Statement > eps
-0.2893483621616363
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29849832
Quarters > 2 > income Statement > income Tax Expense
2000
Quarters > 2 > income Statement > EBITDA
-7243000
Quarters > 2 > income Statement > operating Margin
-247.70348837209303
Quarters > 2 > income Statement > total Other Income Expense Net
-114000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10723000
Quarters > 2 > balance Sheet > short Term Investments
4973000
Quarters > 2 > balance Sheet > receivables
2997000
Quarters > 2 > balance Sheet > inventories
3669000
Quarters > 2 > balance Sheet > total Current Assets
23395000
Quarters > 2 > balance Sheet > property Plant Equipment
34972000
Quarters > 2 > balance Sheet > total Assets
63331000
Quarters > 2 > balance Sheet > payables
1905000
Quarters > 2 > balance Sheet > short Term Debt
1988000
Quarters > 2 > balance Sheet > long Term Debt
5223000
Quarters > 2 > balance Sheet > total Liabilities
41682000
Quarters > 2 > balance Sheet > equity
21649000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-8637000
Quarters > 2 > cash Flow > depreciation
1175000
Quarters > 2 > cash Flow > change In Working Capital
3385000
Quarters > 2 > cash Flow > cash From Operations
-3237000
Quarters > 2 > cash Flow > capital Expenditures
502000
Quarters > 2 > cash Flow > cash From Investing
12248000
Quarters > 2 > cash Flow > cash From Financing
-27000
Quarters > 2 > cash Flow > net Change In Cash
8978000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.2893483621616363
Quarters > 2 > ratios > PB
0.0703192494803455
Quarters > 2 > ratios > ROE
-39.89560718739896
Quarters > 2 > ratios > ROA
-13.637870868926749
Quarters > 2 > ratios > FCF
-3739000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0869186046511627
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
6977000
Quarters > 3 > income Statement > cost Of Revenue
2881000
Quarters > 3 > income Statement > gross Profit
4096000
Quarters > 3 > income Statement > operating Expenses
10188000
Quarters > 3 > income Statement > operating Income
-6092000
Quarters > 3 > income Statement > interest Expense
514000
Quarters > 3 > income Statement > pretax Income
-17684000
Quarters > 3 > income Statement > net Income
-17687000
Quarters > 3 > income Statement > eps
-0.5893624525768488
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
30010395
Quarters > 3 > income Statement > income Tax Expense
3000
Quarters > 3 > income Statement > EBITDA
-16019000
Quarters > 3 > income Statement > operating Margin
-87.31546509961301
Quarters > 3 > income Statement > total Other Income Expense Net
-11592000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1570000
Quarters > 3 > balance Sheet > short Term Investments
17588000
Quarters > 3 > balance Sheet > receivables
5985000
Quarters > 3 > balance Sheet > inventories
4025000
Quarters > 3 > balance Sheet > total Current Assets
30351000
Quarters > 3 > balance Sheet > property Plant Equipment
34520000
Quarters > 3 > balance Sheet > total Assets
70411000
Quarters > 3 > balance Sheet > payables
3284000
Quarters > 3 > balance Sheet > short Term Debt
1822000
Quarters > 3 > balance Sheet > long Term Debt
5269000
Quarters > 3 > balance Sheet > total Liabilities
40873000
Quarters > 3 > balance Sheet > equity
29538000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-17687000
Quarters > 3 > cash Flow > depreciation
1151000
Quarters > 3 > cash Flow > change In Working Capital
-3897000
Quarters > 3 > cash Flow > cash From Operations
-7312000
Quarters > 3 > cash Flow > capital Expenditures
252000
Quarters > 3 > cash Flow > cash From Investing
6495000
Quarters > 3 > cash Flow > cash From Financing
-15021000
Quarters > 3 > cash Flow > net Change In Cash
-15825000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5893624525768488
Quarters > 3 > ratios > PB
0.051815632236441186
Quarters > 3 > ratios > ROE
-59.8788001895863
Quarters > 3 > ratios > ROA
-25.119654599423384
Quarters > 3 > ratios > FCF
-7564000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.0841335817686686
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
27509000
Annuals > 0 > income Statement > cost Of Revenue
10559000
Annuals > 0 > income Statement > gross Profit
16950000
Annuals > 0 > income Statement > operating Expenses
63489000
Annuals > 0 > income Statement > operating Income
-46539000
Annuals > 0 > income Statement > interest Expense
3105000
Annuals > 0 > income Statement > pretax Income
-47700000
Annuals > 0 > income Statement > net Income
-47724000
Annuals > 0 > income Statement > eps
-1.5945144746191078
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29930114
Annuals > 0 > income Statement > income Tax Expense
24000
Annuals > 0 > income Statement > EBITDA
-40493000
Annuals > 0 > income Statement > operating Margin
-169.17736013668255
Annuals > 0 > income Statement > total Other Income Expense Net
-1161000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1570000
Annuals > 0 > balance Sheet > short Term Investments
17588000
Annuals > 0 > balance Sheet > receivables
5985000
Annuals > 0 > balance Sheet > inventories
4025000
Annuals > 0 > balance Sheet > total Current Assets
30351000
Annuals > 0 > balance Sheet > property Plant Equipment
34520000
Annuals > 0 > balance Sheet > total Assets
70411000
Annuals > 0 > balance Sheet > payables
3284000
Annuals > 0 > balance Sheet > short Term Debt
1822000
Annuals > 0 > balance Sheet > long Term Debt
5269000
Annuals > 0 > balance Sheet > total Liabilities
40873000
Annuals > 0 > balance Sheet > equity
29538000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-47724000
Annuals > 0 > cash Flow > depreciation
4102000
Annuals > 0 > cash Flow > change In Working Capital
-7766000
Annuals > 0 > cash Flow > cash From Operations
-34667000
Annuals > 0 > cash Flow > capital Expenditures
1980000
Annuals > 0 > cash Flow > cash From Investing
-5744000
Annuals > 0 > cash Flow > cash From Financing
11565000
Annuals > 0 > cash Flow > net Change In Cash
-28849000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.5945144746191078
Annuals > 0 > ratios > PB
0.05066374500643239
Annuals > 0 > ratios > ROE
-161.56814950233598
Annuals > 0 > ratios > ROA
-67.77918223004929
Annuals > 0 > ratios > FCF
-36647000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.3321821949180268
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
27435000
Annuals > 1 > income Statement > cost Of Revenue
11840000
Annuals > 1 > income Statement > gross Profit
15595000
Annuals > 1 > income Statement > operating Expenses
62080000
Annuals > 1 > income Statement > operating Income
-46485000
Annuals > 1 > income Statement > interest Expense
1955000
Annuals > 1 > income Statement > pretax Income
-48447000
Annuals > 1 > income Statement > net Income
-48471000
Annuals > 1 > income Statement > eps
-1.6451279947321693
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29463361
Annuals > 1 > income Statement > income Tax Expense
24000
Annuals > 1 > income Statement > EBITDA
-43617000
Annuals > 1 > income Statement > operating Margin
-169.43685073810826
Annuals > 1 > income Statement > total Other Income Expense Net
-1962000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
30419000
Annuals > 1 > balance Sheet > short Term Investments
13159000
Annuals > 1 > balance Sheet > receivables
5851000
Annuals > 1 > balance Sheet > inventories
2200000
Annuals > 1 > balance Sheet > total Current Assets
55092000
Annuals > 1 > balance Sheet > property Plant Equipment
8521000
Annuals > 1 > balance Sheet > total Assets
81362000
Annuals > 1 > balance Sheet > payables
1295000
Annuals > 1 > balance Sheet > short Term Debt
637000
Annuals > 1 > balance Sheet > long Term Debt
19649000
Annuals > 1 > balance Sheet > total Liabilities
34797000
Annuals > 1 > balance Sheet > equity
46565000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-48471000
Annuals > 1 > cash Flow > depreciation
2875000
Annuals > 1 > cash Flow > change In Working Capital
2130000
Annuals > 1 > cash Flow > cash From Operations
-38715000
Annuals > 1 > cash Flow > capital Expenditures
4468000
Annuals > 1 > cash Flow > cash From Investing
-18007000
Annuals > 1 > cash Flow > cash From Financing
4510000
Annuals > 1 > cash Flow > net Change In Cash
-52212000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.6451279947321693
Annuals > 1 > ratios > PB
0.03163680983571352
Annuals > 1 > ratios > ROE
-104.09320304950069
Annuals > 1 > ratios > ROA
-59.574494235638255
Annuals > 1 > ratios > FCF
-43183000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.5740112994350282
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
11043000
Annuals > 2 > income Statement > cost Of Revenue
6744000
Annuals > 2 > income Statement > gross Profit
4299000
Annuals > 2 > income Statement > operating Expenses
39673000
Annuals > 2 > income Statement > operating Income
-35374000
Annuals > 2 > income Statement > interest Expense
1369000
Annuals > 2 > income Statement > pretax Income
-38944000
Annuals > 2 > income Statement > net Income
-38958000
Annuals > 2 > income Statement > eps
-1.3287820439313258
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
29318578
Annuals > 2 > income Statement > income Tax Expense
14000
Annuals > 2 > income Statement > EBITDA
-36001000
Annuals > 2 > income Statement > operating Margin
-320.32962057411936
Annuals > 2 > income Statement > total Other Income Expense Net
-3570000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
82806000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
3665000
Annuals > 2 > balance Sheet > inventories
2368000
Annuals > 2 > balance Sheet > total Current Assets
93184000
Annuals > 2 > balance Sheet > property Plant Equipment
5737000
Annuals > 2 > balance Sheet > total Assets
116257000
Annuals > 2 > balance Sheet > payables
2499000
Annuals > 2 > balance Sheet > short Term Debt
1840000
Annuals > 2 > balance Sheet > long Term Debt
14088000
Annuals > 2 > balance Sheet > total Liabilities
25473000
Annuals > 2 > balance Sheet > equity
90784000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-38958000
Annuals > 2 > cash Flow > depreciation
1574000
Annuals > 2 > cash Flow > change In Working Capital
-3037000
Annuals > 2 > cash Flow > cash From Operations
-36698000
Annuals > 2 > cash Flow > capital Expenditures
1854000
Annuals > 2 > cash Flow > cash From Investing
-15040000
Annuals > 2 > cash Flow > cash From Financing
121081000
Annuals > 2 > cash Flow > net Change In Cash
69343000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.3287820439313258
Annuals > 2 > ratios > PB
0.016147436772999648
Annuals > 2 > ratios > ROE
-42.91284807895664
Annuals > 2 > ratios > ROA
-33.51024024359823
Annuals > 2 > ratios > FCF
-38552000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.491080322376166
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
6576000
Annuals > 3 > income Statement > cost Of Revenue
2951000
Annuals > 3 > income Statement > gross Profit
3625000
Annuals > 3 > income Statement > operating Expenses
19986000
Annuals > 3 > income Statement > operating Income
-16361000
Annuals > 3 > income Statement > interest Expense
690000
Annuals > 3 > income Statement > pretax Income
-18005000
Annuals > 3 > income Statement > net Income
-18010000
Annuals > 3 > income Statement > eps
-0.6161702647109881
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
29228934
Annuals > 3 > income Statement > income Tax Expense
5000
Annuals > 3 > income Statement > EBITDA
-15858000
Annuals > 3 > income Statement > operating Margin
-248.79866180048663
Annuals > 3 > income Statement > total Other Income Expense Net
-1644000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
13463000
Annuals > 3 > balance Sheet > short Term Investments
312001000
Annuals > 3 > balance Sheet > receivables
2266000
Annuals > 3 > balance Sheet > inventories
601000
Annuals > 3 > balance Sheet > total Current Assets
17181000
Annuals > 3 > balance Sheet > property Plant Equipment
3779000
Annuals > 3 > balance Sheet > total Assets
26863000
Annuals > 3 > balance Sheet > payables
1191000
Annuals > 3 > balance Sheet > short Term Debt
2116000
Annuals > 3 > balance Sheet > long Term Debt
3353000
Annuals > 3 > balance Sheet > total Liabilities
52322000
Annuals > 3 > balance Sheet > equity
-25459000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-18010000
Annuals > 3 > cash Flow > depreciation
1457000
Annuals > 3 > cash Flow > change In Working Capital
-20000
Annuals > 3 > cash Flow > cash From Operations
-15381000
Annuals > 3 > cash Flow > capital Expenditures
204000
Annuals > 3 > cash Flow > cash From Investing
-204000
Annuals > 3 > cash Flow > cash From Financing
-96000
Annuals > 3 > cash Flow > net Change In Cash
-15681000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.6161702647109881
Annuals > 3 > ratios > PB
-0.057403931811932915
Annuals > 3 > ratios > ROE
70.74119172002042
Annuals > 3 > ratios > ROA
-67.04388936455348
Annuals > 3 > ratios > FCF
-15585000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.3699817518248176
Annuals > 3 > health Score
30
Valuation > metrics > PE
-3.7469050800970067
Valuation > metrics > PB
0.02333655472379969
Valuation > final Score
70
Valuation > verdict
97.7% Undervalued
Profitability > metrics > ROE
-171.45069695405266
Profitability > metrics > ROA
-81.79802955665025
Profitability > metrics > Net Margin
-4.241379310344827
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
5.3853897780072275
Risk > metrics > Interest Coverage
-25.009132420091323
Risk > final Score
-94
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.3755717431814332
Liquidity > metrics > Quick Ratio
1.189395222768084
Liquidity > final Score
84
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-190
Prev Risks > 1
-127
Prev Risks > 2
-17
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:40:18.788Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-11
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-4.0938
Earnings History > 0 > eps Estimate
-6.58
Earnings History > 0 > eps Difference
2.4862
Earnings History > 0 > surprise Percent
37.7842
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-08-07
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-7.62
Earnings History > 1 > eps Estimate
-4.03
Earnings History > 1 > eps Difference
-3.59
Earnings History > 1 > surprise Percent
-89.0819
Earnings History > 2 > period
2024-03-31
Earnings History > 2 > report Date
2024-05-09
Earnings History > 2 > date
2024-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-5.52
Earnings History > 2 > eps Estimate
-4.14
Earnings History > 2 > eps Difference
-1.38
Earnings History > 2 > surprise Percent
-33.3333
Earnings History > 3 > period
2023-12-31
Earnings History > 3 > report Date
2024-03-28
Earnings History > 3 > date
2023-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.23
Earnings History > 3 > eps Estimate
-0.22
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-4.5455
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-13
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.37
Earnings History > 4 > eps Estimate
-0.3
Earnings History > 4 > eps Difference
-0.07
Earnings History > 4 > surprise Percent
-23.3333
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-08-10
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.28
Earnings History > 5 > eps Estimate
-0.32
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
12.5
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-11
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.37
Earnings History > 6 > eps Estimate
-0.37
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2022-12-31
Earnings History > 7 > report Date
2023-03-21
Earnings History > 7 > date
2022-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.28
Earnings History > 7 > eps Estimate
-0.41
Earnings History > 7 > eps Difference
0.13
Earnings History > 7 > surprise Percent
31.7073
Earnings History > 8 > period
2022-09-30
Earnings History > 8 > report Date
2022-11-08
Earnings History > 8 > date
2022-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.42
Earnings History > 8 > eps Estimate
-0.48
Earnings History > 8 > eps Difference
0.06
Earnings History > 8 > surprise Percent
12.5
Earnings History > 9 > period
2022-06-30
Earnings History > 9 > report Date
2022-08-09
Earnings History > 9 > date
2022-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.5
Earnings History > 9 > eps Estimate
-0.51
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
1.9608
Earnings History > 10 > period
2022-03-31
Earnings History > 10 > report Date
2022-05-11
Earnings History > 10 > date
2022-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.45
Earnings History > 10 > eps Estimate
-0.43
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-4.6512
Earnings History > 11 > period
2021-12-31
Earnings History > 11 > report Date
2022-03-22
Earnings History > 11 > date
2021-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.43
Earnings History > 11 > eps Estimate
-0.37
Earnings History > 11 > eps Difference
-0.06
Earnings History > 11 > surprise Percent
-16.2162
Earnings History > 12 > period
2021-09-30
Earnings History > 12 > report Date
2021-11-09
Earnings History > 12 > date
2021-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.34
Earnings History > 12 > eps Estimate
-0.28
Earnings History > 12 > eps Difference
-0.06
Earnings History > 12 > surprise Percent
-21.4286
Earnings History > 13 > period
2021-06-30
Earnings History > 13 > report Date
2021-08-10
Earnings History > 13 > date
2021-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.06
Earnings History > 13 > eps Estimate
-0.35
Earnings History > 13 > eps Difference
-0.71
Earnings History > 13 > surprise Percent
-202.8571
Earnings History > 14 > period
2021-03-31
Earnings History > 14 > report Date
2021-06-21
Earnings History > 14 > date
2021-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.34
Earnings History > 14 > eps Estimate
-0.07
Earnings History > 14 > eps Difference
-0.27
Earnings History > 14 > surprise Percent
-385.7143
Earnings History > 15 > period
2020-12-31
Earnings History > 15 > report Date
2021-02-25
Earnings History > 15 > date
2020-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.22
Earnings History > 15 > eps Estimate
-0.24
Earnings History > 15 > eps Difference
0.02
Earnings History > 15 > surprise Percent
8.3333
Earnings History > 16 > period
2020-09-30
Earnings History > 16 > report Date
2020-11-05
Earnings History > 16 > date
2020-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.23
Earnings History > 16 > eps Estimate
0.2
Earnings History > 16 > eps Difference
0.03
Earnings History > 16 > surprise Percent
15
Earnings History > 17 > period
2020-06-30
Earnings History > 17 > report Date
2020-08-06
Earnings History > 17 > date
2020-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.58
Earnings History > 17 > eps Estimate
-0.43
Earnings History > 17 > eps Difference
-0.15
Earnings History > 17 > surprise Percent
-34.8837
Earnings History > 18 > period
2020-03-31
Earnings History > 18 > report Date
2020-05-07
Earnings History > 18 > date
2020-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.24
Earnings History > 18 > eps Estimate
-0.46
Earnings History > 18 > eps Difference
0.22
Earnings History > 18 > surprise Percent
47.8261
Earnings History > 19 > period
2019-12-31
Earnings History > 19 > report Date
2020-03-12
Earnings History > 19 > date
2019-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.48
Earnings History > 19 > eps Estimate
-0.42
Earnings History > 19 > eps Difference
-0.06
Earnings History > 19 > surprise Percent
-14.2857
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-11-06
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.41
Earnings History > 20 > eps Estimate
-0.46
Earnings History > 20 > eps Difference
0.05
Earnings History > 20 > surprise Percent
10.8696
Earnings History > 21 > period
2019-06-30
Earnings History > 21 > report Date
2019-07-31
Earnings History > 21 > date
2019-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.57
Earnings History > 21 > eps Estimate
-0.48
Earnings History > 21 > eps Difference
-0.09
Earnings History > 21 > surprise Percent
-18.75
Earnings History > 22 > period
2019-03-31
Earnings History > 22 > report Date
2019-05-09
Earnings History > 22 > date
2019-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.74
Earnings History > 22 > eps Estimate
-0.48
Earnings History > 22 > eps Difference
-0.26
Earnings History > 22 > surprise Percent
-54.1667
Earnings History > 23 > period
2018-12-31
Earnings History > 23 > report Date
2019-03-21
Earnings History > 23 > date
2018-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.13
Earnings History > 23 > eps Estimate
-0.21
Earnings History > 23 > eps Difference
0.08
Earnings History > 23 > surprise Percent
38.0952
Earnings History > 24 > period
2018-09-30
Earnings History > 24 > report Date
2018-11-08
Earnings History > 24 > date
2018-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.97
Earnings History > 24 > eps Estimate
-0.04
Earnings History > 24 > eps Difference
-0.93
Earnings History > 24 > surprise Percent
-2325
Earnings History > 25 > period
2018-06-30
Earnings History > 25 > report Date
2018-08-08
Earnings History > 25 > date
2018-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-2.94
Earnings History > 25 > eps Estimate
-0.62
Earnings History > 25 > eps Difference
-2.32
Earnings History > 25 > surprise Percent
-374.1935
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. It has license agreement with Regeneron Pharmaceuticals, Inc. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AINmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial MSN
Read more →Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens - TechStock²
1/13/2026
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens TechStock²
Read more →Showing 2 of 10
(Last Updated 2024-09-30)
Rating:
STRONG BUY
Target Price:
$4
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Telesis Bio Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
-4.0938
EPS Estimate
-6.58
EPS Difference
2.4862
Surprise Percent
37.7842%
(Last Updated 2024-09-30)
(Last Updated 2024-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.